Graft-versus-host disease: The influence of type 1 and type 2 T cell cytokines

被引：44
作者：
Ferrara, JLM
Krenger, W
机构：
[1] Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Boston, MA 02115 USA
来源：
TRANSFUSION MEDICINE REVIEWS | 1998年 / 12卷 / 01期
关键词：
D O I：
10.1016/S0887-7963(98)80085-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 17
页数：17
相关论文
共 174 条
[1]   INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT-VERSUS-HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS [J].
ABHYANKAR, S ;
GILLILAND, DG ;
FERRARA, JLM .
TRANSPLANTATION, 1993, 56 (06) :1518-1523
[2]  
ALBINA JE, 1991, J IMMUNOL, V147, P144
[3]   DIFFERENTIAL CYTOKINE EXPRESSION IN ACUTE AND CHRONIC MURINE GRAFT-VERSUS-HOST-DISEASE [J].
ALLEN, RD ;
STALEY, TA ;
SIDMAN, CL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) :333-337
[4]   A PHASE-I PHASE-II STUDY EVALUATING THE MURINE ANTI-IL-2 RECEPTOR ANTIBODY-2A3 FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE [J].
ANASETTI, C ;
MARTIN, PJ ;
HANSEN, JA ;
APPELBAUM, FR ;
BEATTY, PG ;
DONEY, K ;
HARKONEN, S ;
JACKSON, A ;
REICHERT, T ;
STEWART, P ;
STORB, R ;
SULLIVAN, KM ;
THOMAS, ED ;
WARNER, N ;
WITHERSPOON, RP .
TRANSPLANTATION, 1990, 50 (01) :49-54
[5]  
ANDERSON KC, 1990, NEW ENGL J MED, V323, P315
[6]  
ANTIN JH, 1992, BLOOD, V80, P2964
[7]  
AREND WP, 1991, J IMMUNOL, V147, P1530
[8]  
AREND WP, 1989, J IMMUNOL, V143, P1851
[9]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[10]  
ATKINSON K, 1991, BLOOD, V77, P1376
12345678910